Dilaudid and Travatan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Travatan (travoprost). Common drug interactions include body height decreased among females and death among males.
The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Travatan. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.
What is Dilaudid?
Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.
What is Travatan?
Travatan has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 13,103 Travatan users. Check the latest studies of Travatan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
40 people who take Dilaudid and Travatan together, and have interactions are studied.

What are the common drug interactions of Dilaudid and Travatan, by gender? *:
female:
- Body height decreased
- Breakthrough pain
- Drug ineffective
- Dysarthria (speech disorder)
- Gingival disorder (gum disease)
- Pain in extremity
- Constipation
- Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
- Vomiting
- Back pain
male:
- Death
- Type 2 diabetes mellitus
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Chronic kidney disease
- Emotional distress
- Renal impairment (severely reduced kidney function)
- Bone density decreased
- Neuropathy peripheral (surface nerve damage)
- Platelet count decreased
- Skin discolouration (change of skin colour)
What are the common drug interactions of Dilaudid and Travatan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Decreased interest
- Dehydration (dryness resulting from the removal of water)
- Delirium (wild excitement)
- Device related infection
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
- Dry mouth
- Dyslipidaemia (abnormal amount of lipids)
- Dyspnoea exertional (breathlessness or shortness of breath)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Erythema (redness of the skin)
50-59:
- Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bone density decreased
- Chronic kidney disease
- Emotional distress
- Osteoporosis (bones weak and more likely to break)
- Renal disorder (kidney disease)
- Renal impairment (severely reduced kidney function)
- Abdominal distension
60+:
- Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
- Fall
- Gingival disorder (gum disease)
- Toothache (tooth pain)
- Back disorder
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Death
- Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
- Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
- Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles)
What are the existing conditions these people have? *
- Depression: 16 people, 40.00%
- Stress And Anxiety: 12 people, 30.00%
- High Blood Pressure: 11 people, 27.50%
- Neuropathy Peripheral (surface nerve damage): 9 people, 22.50%
- Urinary Tract Infection: 8 people, 20.00%
- Inflammation: 8 people, 20.00%
- Cataract (clouding of the lens inside the eye): 8 people, 20.00%
- Diabetes: 8 people, 20.00%
- Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 8 people, 20.00%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 8 people, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Dilaudid and Travatan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dilaudid and Travatan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dilaudid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Travatan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dilaudid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Travatan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on hydromorphone hydrochloride and travoprost (the active ingredients of Dilaudid and Travatan, respectively), and Dilaudid and Travatan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Temazepam cause Asphyxia? - 4 seconds ago
- Could Enalapril Maleate cause Incontinence? - 6 seconds ago
- Could Copegus cause Protein - Urine? - 10 seconds ago
- Could Benicar cause Joint Stiffness? - 10 seconds ago
- Quadriplegia and Drowsiness - 12 seconds ago
- Drug interactions of Lovastatin and Hydroxyzine Pamoate - 13 seconds ago
- Could Fluorometholone cause White Blood Cell Count Increased? - 32 seconds ago
- Drug interactions of Jardiance and Furosemide - 35 seconds ago
- Could Tegretol cause Spinal Disorder? - 38 seconds ago
- Drug interactions of Doxylamine Succinate and Loratadine - 39 seconds ago